April 27, 2021
FDA: Class I recall of Cordis Precise PRO Rx US Carotid System
Editor's Note
The Food and Drug Administration (FDA), on April 26, identified the recall by Cordis Corporation of its Precise PRO Rx US Carotid System as Class I, the most serious.
The Carotid System is being recalled due to a risk of separation of the atraumatic distal tip of the sheathed delivery system in patients.
The System, which is used to treat patients with narrowed carotid arteries, includes a metal self-expanding stent preloaded on a delivery catheter.
There have been seven complaints, including five injuries. No deaths have been reported.
Distribution dates were December 6, 2019, to February 8, 2021.
Free Daily News
- AAMI, CTA partners to develop healthcare AI standards
- ECRI issues guidance to address medical supply shortages caused by Hurricane Helene, dockworkers’ strike
- FDA designates Class 1 recall for IPV therapy system
- Study: Early detection of atherosclerosis linked to lower mortality risk
- Repeal of CON laws for ASCs expands healthcare access, number of facilities in rural areas
- Spatial computing trial shows promise for enhancing OR efficiency, reducing strain on surgeons
- Vice presidential debate highlights healthcare, abortion policy differences
- FDA designates Class 1 recalls for infusion pump software, ventilator software
- Health systems face declining margins, cut leadership amid rising costs
- Hurricane disrupts IV fluid manufacturing as hospitals cope with chaos
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement